Considerable variability found between 25-D assays. |
EurekAlert: The researchers performed statistical analysis (linear regression and bias analysis) of the results. In 40 percent of the Architect-tested specimens and in 48 percent of the Centaur2-tested specimens, the results were at least 25 percent too high or 25 percent too low, compared with the third technique, Holmes reported. The maximum recommended allowable error for 25-hydroxyvitamin D tests is plus or minus 25 percent, and he stated that the sizes of the observed errors ranged from ? to +80 percent.
|
Atkins diets increase rate of calories burned, but also increase cardiovascular risk in women. |
EurekAlert: Women who regularly eat a low carbohydrate, high protein diet are at greater risk of cardiovascular disease (such as heart disease and stroke) than those who do not, a study published on bmj.com today suggests. Although the actual numbers are small (an extra 4-5 cases of cardiovascular disease per 10,000 women per year) the authors say that this is a 28% increase in the number of cases and that these results are worrying in a population of young women who may be exposed to these dietary patterns and face the excess risk for many years.
|
Greece Nephrology and Urology Devices Investment Opportunities, Analysis ... - SBWire (press release) |
Boston, MA -- (SBWIRE) -- 06/27/2012 -- "Greece Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018", a new report by Global Markets Direct, provides key market data on the Greece Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
View Full Report Details and Table of Contents
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.
Scope
- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Greece Nephrology and Urology Devicesmarket.
- Key players covered include Fresenius Medical Care AG & Co. KGaA, Gambro AB, Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., HARTMANN GROUP, B. Braun Melsungen AG and others.
Reasons to Get this Report
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Greece Nephrology and Urology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Companies Mentioned in this Report: Fresenius Medical Care AG & Co. KGaA, Gambro AB, Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., HARTMANN GROUP, B. Braun Melsungen AG, ONTEX International N.V., First Quality Enterprises, Inc., Coloplast A/S, Kimberly-Clark Corporation, Covidien plc, Teleflex Incorporated, Medline Industries, Inc., C. R. Bard, Inc., Siemens Healthcare, Dornier MedTech GmbH
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- Portugal Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Switzerland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Egypt Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- United Arab Emirates Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Ireland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Chile Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Poland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Hungary Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
|
Greece Nephrology and Urology Devices Investment Opportunities ... - SBWire (press release) |
Boston, MA -- (SBWIRE) -- 06/27/2012 -- "Greece Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018", a new report by Global Markets Direct, provides key market data on the Greece Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
View Full Report Details and Table of Contents
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.
Scope
- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Greece Nephrology and Urology Devicesmarket.
- Key players covered include Fresenius Medical Care AG & Co. KGaA, Gambro AB, Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., HARTMANN GROUP, B. Braun Melsungen AG and others.
Reasons to Get this Report
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Greece Nephrology and Urology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Companies Mentioned in this Report: Fresenius Medical Care AG & Co. KGaA, Gambro AB, Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., HARTMANN GROUP, B. Braun Melsungen AG, ONTEX International N.V., First Quality Enterprises, Inc., Coloplast A/S, Kimberly-Clark Corporation, Covidien plc, Teleflex Incorporated, Medline Industries, Inc., C. R. Bard, Inc., Siemens Healthcare, Dornier MedTech GmbH
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- Portugal Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Switzerland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Egypt Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- United Arab Emirates Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Ireland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Chile Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Poland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
- Hungary Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018
|
|
|